Literature DB >> 10764022

Extracorporeal shock wave lithotripsy of gallstones revisited: current status and future promises.

E Mulagha1, H Fromm.   

Abstract

The improvement and refinement of extracorporeal shock wave lithotripsy (ESWL) has made this non-invasive treatment modality not only more effective, but also applicable to a larger population of gallstone patients. It can be performed safely on an outpatient basis. Advances in lithotripsy technology have made it possible to fragment stones into very small, sand-like particles (pulverization), which clear the gall-bladder faster than large fragments. Recent studies provide evidence that adjuvant bile acids may not be necessary in most cases in which pulverization is achieved. Good gall-bladder emptying appears both to promote the clearance of gallstones after ESWL and to decrease their recurrence. Although generally found to be more expensive than surgery if bile acids are used, ESWL should be cost-effective, as bile acids may not be necessary in all patients. Elderly patients with radiolucent, solitary and less than 30 mm gallstones can particularly benefit from lithotripsy.

Entities:  

Mesh:

Year:  2000        PMID: 10764022     DOI: 10.1046/j.1440-1746.2000.02094.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  3 in total

1.  ESWL for difficult bile duct stones: a 15-year single centre experience.

Authors:  Rosangela Muratori; Francesco Azzaroli; Federica Buonfiglioli; Flavio Alessandrelli; Paolo Cecinato; Giuseppe Mazzella; Enrico Roda
Journal:  World J Gastroenterol       Date:  2010-09-07       Impact factor: 5.742

2.  The effect of extracorporeal shock wave lithotripsy in the management of idiopathic gallstones in children.

Authors:  Seyed Abdollah Mousavi; Hasan Karami; Ayub Barzegarnejad
Journal:  J Indian Assoc Pediatr Surg       Date:  2014-10

3.  Cost-effectiveness of extracorporeal shock wave lithotripsy in a poor resource setting: The Okada, Nigeria experience.

Authors:  Kenneth C Eze; E Irekpita; T A Salami
Journal:  Niger Med J       Date:  2016 Jan-Feb
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.